Racial and Ethnic Disparities in Gene-Expression Profiling Tests in Breast Cancer

By The ASCO Post
Posted: 3/31/2017 12:17:30 PM
Last Updated: 3/31/2017 12:17:30 PM
Tweet this page

Key Points

White patients were more likely to receive ODx testing than black and Hispanic women: 51.4% vs 44.6% and 47.7%, respectively.
Significant testing variation between the white, black, and Hispanic patients were also noted in the non-Guidelines–recommended group: 21.2% vs 9.0% and 9.7%, respectively.
Also noted in the study, between 2011 and 2013, the NCCN Guidelines for Breast Cancer did not recommend ODx for patients with higher-risk disease, yet more than 18%—or 1,100 women—received ODx testing.